CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
6.04
4.88%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Fri: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.09
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Health Catalyst Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 6.35
Open* 6.26
1-Year Change* -51.51%
Day's Range* 5.96 - 6.27
52 wk Range 6.60-15.87
Average Volume (10 days) 656.68K
Average Volume (3 months) 11.63M
Market Cap 565.72M
P/E Ratio -100.00K
Shares Outstanding 57.55M
Revenue 290.02M
EPS -2.23
Dividend (Yield %) N/A
Beta 1.35
Next Earnings Date Feb 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 12, 2024 6.04 -0.23 -3.67% 6.27 6.31 5.95
Apr 11, 2024 6.35 0.13 2.09% 6.22 6.36 6.17
Apr 10, 2024 6.18 0.01 0.16% 6.17 6.37 6.02
Apr 9, 2024 6.63 0.06 0.91% 6.57 6.85 6.51
Apr 8, 2024 6.54 -0.03 -0.46% 6.57 6.66 6.50
Apr 5, 2024 6.53 -0.04 -0.61% 6.57 6.70 6.49
Apr 4, 2024 6.62 -0.10 -1.49% 6.72 6.89 6.61
Apr 3, 2024 6.64 -0.21 -3.07% 6.85 6.85 6.63
Apr 2, 2024 6.91 -0.25 -3.49% 7.16 7.20 6.88
Apr 1, 2024 7.24 -0.27 -3.60% 7.51 7.51 7.23
Mar 28, 2024 7.48 0.07 0.94% 7.41 7.70 7.41
Mar 27, 2024 7.39 -0.11 -1.47% 7.50 7.51 7.37
Mar 26, 2024 7.44 -0.03 -0.40% 7.47 7.55 7.39
Mar 25, 2024 7.42 -0.30 -3.89% 7.72 7.92 7.42
Mar 22, 2024 7.78 -0.26 -3.23% 8.04 8.07 7.77
Mar 21, 2024 8.07 0.05 0.62% 8.02 8.18 7.92
Mar 20, 2024 8.00 0.22 2.83% 7.78 8.08 7.67
Mar 19, 2024 7.88 0.31 4.10% 7.57 7.98 7.57
Mar 18, 2024 7.58 -0.19 -2.45% 7.77 7.84 7.56
Mar 15, 2024 7.78 0.02 0.26% 7.76 7.98 7.63

Health Catalyst Events

Time (UTC) Country Event
Tuesday, May 7, 2024

Time (UTC)

20:00

Country

US

Event

Q1 2024 Health Catalyst Inc Earnings Release
Q1 2024 Health Catalyst Inc Earnings Release

Forecast

-

Previous

-
Thursday, June 13, 2024

Time (UTC)

19:00

Country

US

Event

Health Catalyst Inc Annual Shareholders Meeting
Health Catalyst Inc Annual Shareholders Meeting

Forecast

-

Previous

-
Tuesday, August 6, 2024

Time (UTC)

10:59

Country

US

Event

Q2 2024 Health Catalyst Inc Earnings Release
Q2 2024 Health Catalyst Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 276.236 241.926 188.845 154.941 112.574
Revenue 276.236 241.926 188.845 154.941 112.574
Cost of Revenue, Total 142.043 124.166 98.077 74.069 59.852
Gross Profit 134.193 117.76 90.768 80.872 52.722
Total Operating Expense 416.241 385.576 293.484 211.476 172.669
Selling/General/Admin. Expenses, Total 148.372 134.121 97.893 79.859 66.813
Research & Development 72.635 61.832 53.517 46.22 38.592
Depreciation / Amortization 48.3 37.5 18.8 9.2 7.412
Operating Income -140.005 -143.65 -104.639 -56.535 -60.095
Interest Income (Expense), Net Non-Operating -1.552 -16.482 -11.622 -3.451 -2.024
Net Income Before Taxes -141.683 -160.108 -116.211 -59.954 -62.119
Net Income After Taxes -137.403 -153.21 -115.017 -60.096 -61.984
Net Income Before Extra. Items -137.403 -153.21 -115.017 -60.096 -61.984
Net Income -137.403 -153.21 -115.017 -60.096 -61.984
Total Adjustments to Net Income 0 0 -180.826 -52.037
Income Available to Common Excl. Extra. Items -137.403 -153.21 -115.017 -240.922 -114.021
Income Available to Common Incl. Extra. Items -137.403 -153.21 -115.017 -240.922 -114.021
Diluted Net Income -137.403 -153.21 -115.017 -240.922 -114.021
Diluted Weighted Average Shares 53.722 47.495 39.541 18.741 35.0782
Diluted EPS Excluding Extraordinary Items -2.55767 -3.22581 -2.9088 -12.8553 -3.25048
Dividends per Share - Common Stock Primary Issue 0
Diluted Normalized EPS -2.4525 -2.81895 -2.72495 -12.7819 -3.25048
Unusual Expense (Income) 4.894 27.929 11.184 2.116
Other Operating Expenses, Total -0.003 0.028 14.013 0.012
Other, Net -0.126 0.024 0.05 0.032
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 73.213 73.868 69.162 68.354 70.633
Revenue 73.213 73.868 69.162 68.354 70.633
Cost of Revenue, Total 39.266 37.686 37.876 36.123 34.373
Gross Profit 33.947 36.182 31.286 32.231 36.26
Total Operating Expense 107.831 108.782 105.907 114.075 103.825
Selling/General/Admin. Expenses, Total 27.668 29.3 35.734 42.211 35.152
Research & Development 17.395 16.602 18.927 20.077 17.041
Depreciation / Amortization 10.7 10.994 11.7 12.4 12.612
Unusual Expense (Income) 12.767 14.2 1.706 3.292 4.647
Other Operating Expenses, Total 0.035 -0.036 -0.028
Operating Income -34.618 -34.914 -36.745 -45.721 -33.192
Interest Income (Expense), Net Non-Operating 2.084 1.788 1.047 0.165 -1.133
Other, Net 0.006 0.005 -0.025 -0.023 -0.047
Net Income Before Taxes -32.528 -33.121 -35.723 -45.579 -34.372
Net Income After Taxes -32.613 -33.19 -35.782 -45.735 -33.428
Net Income Before Extra. Items -32.613 -33.19 -35.782 -45.735 -33.428
Net Income -32.613 -33.19 -35.782 -45.735 -33.428
Income Available to Common Excl. Extra. Items -32.613 -33.19 -35.782 -45.735 -33.428
Income Available to Common Incl. Extra. Items -32.613 -33.19 -35.782 -45.735 -33.428
Diluted Net Income -32.613 -33.19 -35.782 -45.735 -33.428
Diluted Weighted Average Shares 55.977 55.485 53.887 54.304 53.675
Diluted EPS Excluding Extraordinary Items -0.58261 -0.59818 -0.66402 -0.8422 -0.62279
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.43437 -0.43183 -0.64226 -0.75851 -0.56651
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 427.795 508.391 329.799 264.239 66.858
Cash and Short Term Investments 363.49 444.981 270.871 228.277 33.192
Cash & Equivalents 116.312 193.227 91.954 18.032 28.431
Short Term Investments 247.178 251.754 178.917 210.245 4.761
Total Receivables, Net 47.97 48.801 48.296 27.57 27.696
Accounts Receivable - Trade, Net 47.97 48.801 48.296 27.57 27.696
Prepaid Expenses 16.335 14.609 10.632 7.455 5.321
Other Current Assets, Total 0.937 0.649
Total Assets 752.286 832.096 577.74 302.36 110.975
Property/Plant/Equipment, Total - Net 42.586 44.449 37.592 8.082 11.02
Property/Plant/Equipment, Total - Gross 60.043 55.882 47.601 17.877 18.714
Accumulated Depreciation, Total -17.457 -11.433 -10.009 -9.795 -7.694
Goodwill, Net 185.982 169.972 107.822 3.694 3.694
Intangibles, Net 92.189 104.788 98.921 25.535 28.304
Other Long Term Assets, Total 3.734 4.496 3.606 0.81 1.099
Total Current Liabilities 82.51 93.051 88.036 48.217 41.806
Accounts Payable 4.424 4.693 5.332 3.622 1.812
Accrued Expenses 23.125 27.15 19.132 11.75 11.78
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0 1.287
Other Current Liabilities, Total 54.961 61.208 63.572 32.845 26.927
Total Liabilities 327.276 309.998 301.641 101.716 75.898
Total Long Term Debt 226.523 180.942 168.994 48.2 18.814
Long Term Debt 226.523 180.942 168.994 48.2 18.814
Other Liabilities, Total 18.243 36.005 44.611 5.299 15.278
Total Equity 425.01 522.098 276.099 200.644 35.077
Redeemable Preferred Stock 0 409.845
Common Stock 0.055 0.053 0.043 0.037 0.01
Additional Paid-In Capital 1424.63 1400.97 1001.65 811.049 0
Retained Earnings (Accumulated Deficit) -999.023 -878.86 -725.65 -610.514 -374.777
Other Equity, Total -0.648 -0.067 0.061 0.072 -0.001
Total Liabilities & Shareholders’ Equity 752.286 832.096 577.74 302.36 110.975
Total Common Shares Outstanding 55.2619 52.6221 43.3769 36.6788 35.0782
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 408.453 410.951 434.517 427.795 443.45
Cash and Short Term Investments 347.697 343.829 356.927 363.49 380.142
Cash & Equivalents 94.971 115.689 133.479 116.312 124.224
Short Term Investments 252.726 228.14 223.448 247.178 255.918
Total Receivables, Net 46.085 52.378 61.862 47.97 49.544
Accounts Receivable - Trade, Net 46.085 52.378 61.862 47.97 49.544
Prepaid Expenses 12.571 12.644 15.728 16.335 13.764
Total Assets 712.92 722.903 752.301 752.286 776.2
Property/Plant/Equipment, Total - Net 41.373 41.846 42.602 42.586 42.296
Property/Plant/Equipment, Total - Gross 66.05 63.969 61.735 60.043 60.779
Accumulated Depreciation, Total -24.677 -22.123 -19.133 -17.457 -18.483
Goodwill, Net 185.982 185.982 185.982 185.982 185.982
Intangibles, Net 71.996 79.041 84.41 92.189 100.653
Other Long Term Assets, Total 5.116 5.083 4.79 3.734 3.819
Total Current Liabilities 84.253 86.759 102.495 82.51 91.066
Accounts Payable 6.327 7.974 9.243 4.424 6.816
Accrued Expenses 24.859 19.259 27.347 23.125 27.869
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases
Other Current Liabilities, Total 53.067 59.526 65.905 54.961 56.381
Total Liabilities 330.526 333.036 347.155 327.276 336.234
Total Long Term Debt 227.655 227.277 226.9 226.523 226.147
Long Term Debt 227.655 227.277 226.9 226.523 226.147
Other Liabilities, Total 18.618 19 17.76 18.243 19.021
Total Equity 382.394 389.867 405.146 425.01 439.966
Common Stock 0.057 0.056 0.056 0.055 0.054
Additional Paid-In Capital 1469.36 1454.84 1437.6 1424.63 1404.03
Retained Earnings (Accumulated Deficit) -1086.86 -1064.83 -1032.21 -999.023 -963.241
Other Equity, Total -0.17 -0.204 -0.295 -0.648 -0.879
Total Liabilities & Shareholders’ Equity 712.92 722.903 752.301 752.286 776.2
Total Common Shares Outstanding 57.0441 56.5416 55.8435 55.2619 54.2138
Other Current Assets, Total 2.1 2.1
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -137.403 -153.21 -115.017 -60.096 -61.984
Cash From Operating Activities -35.27 -23.123 -26.148 -32.184 -40.296
Cash From Operating Activities 48.297 37.528 18.725 9.212 7.412
Non-Cash Items 72.266 95.077 75.244 22.483 0.583
Cash Taxes Paid 0.297 0.138 0.092 0.019 0.031
Cash Interest Paid 5.75 6.36 4.979 5.557 3.937
Changes in Working Capital -13.907 4.616 -3.827 -3.823 13.693
Cash From Investing Activities -39.021 -139.678 -82.565 -209.602 21.403
Capital Expenditures -17.414 -18.467 -10.465 -4.334 -2.503
Other Investing Cash Flow Items, Total -21.607 -121.211 -72.1 -205.268 23.906
Cash From Financing Activities -2.613 264.084 182.609 231.381 24.346
Financing Cash Flow Items -1.342 -6.29 -1.624 40.846 -3.974
Issuance (Retirement) of Stock, Net -1.271 270.374 40.537 212.356 28.32
Net Change in Cash -76.915 101.273 73.922 -10.399 5.453
Deferred Taxes -4.523 -7.134 -1.273 0.04
Issuance (Retirement) of Debt, Net 0 0 143.696 -21.821
Foreign Exchange Effects -0.011 -0.01 0.026 0.006
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -33.19 -137.403 -101.621 -55.886 -22.458
Cash From Operating Activities -5.58 -35.27 -20.449 -8.418 1.158
Cash From Operating Activities 10.994 48.297 36.633 24.261 11.649
Deferred Taxes 0.002 -4.523 -4.527 -4.529 -3.598
Non-Cash Items 14.579 72.266 53.982 31.142 10.697
Changes in Working Capital 2.035 -13.907 -4.916 -3.406 4.868
Cash From Investing Activities 22.649 -39.021 -45.277 -12.095 1.656
Capital Expenditures -3.387 -17.414 -13.093 -8.882 -4.08
Other Investing Cash Flow Items, Total 26.036 -21.607 -32.184 -3.213 5.736
Cash From Financing Activities 0.093 -2.613 -3.25 4.289 2.388
Financing Cash Flow Items 0 -1.342 -1.342 -0.93 -0.93
Issuance (Retirement) of Stock, Net 0.093 -1.271 -1.908 5.219 3.318
Foreign Exchange Effects 0.005 -0.011 -0.027 -0.02 -0.001
Net Change in Cash 17.167 -76.915 -69.003 -16.244 5.201
Issuance (Retirement) of Debt, Net 0

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Health Catalyst Company profile

About Health Catalyst Inc

Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company operates in two segments: technology and professional services. The technology segment includes its data platform, analytics applications and support services. Its solution consists of a cloud-based data platform, analytics software and professional services expertise. Its cloud-based data operating system (DOS) is a healthcare-specific, open, flexible, and scalable data platform that provides customers with a single comprehensive environment to integrate and organize data from its software systems, which enables a range of analytics. Its software analytics application is built on top of its data platform to provide foundational or domain-specific insights that improve customers clinical, financial and operational performance. Its support services consist of both analytics experts and domain experts.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Health Catalyst Inc revenues increased 28% to $241.9M. Net loss increased 33% to $153.2M. Revenues reflect Technology segment increase of 34% to $147.7M, Professional Services segment increase of 20% to $94.2M. Higher net loss reflects Acquisition transaction costs increase from $2.7M to $26.2M (expense), Total Amort of Intangibles-excl Goodwill increase from $15.9M to $32M (expense).

Industry: Application Software

10897 South River Front Parkway, #300
SOUTH JORDAN
UTAH 84095
US

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

Gold

2,344.52 Price
-1.190% 1D Chg, %
Long position overnight fee -0.0193%
Short position overnight fee 0.0110%
Overnight fee time 21:00 (UTC)
Spread 0.50

BTC/USD

64,665.40 Price
+4.180% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.50 Price
+14.340% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

18,006.40 Price
-1.660% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading